Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2012

Open Access 01-12-2012 | Research article

Crude aqueous extracts of Pluchea indica (L.) Less. inhibit proliferation and migration of cancer cells through induction of p53-dependent cell death

Authors: Jonathan J Cho, Chung-Lung Cho, Chiu-Li Kao, Chien-Ming Chen, Chao-Neng Tseng, Ya-Zhe Lee, Li-Jen Liao, Yi-Ren Hong

Published in: BMC Complementary Medicine and Therapies | Issue 1/2012

Login to get access

Abstract

Background

Pluchea indica (L.) Less. (Asteraceae) is a perennial shrub plant with anti-inflammatory and antioxidant medicinal properties. However, the anti-cancer properties of its aqueous extracts have not been studied. The aim of this study was to investigate the anti-proliferation, anti-migration, and pro-apoptotic properties of crude aqueous extracts of P. indica leaf and root on human malignant glioma cancer cells and human cervical cancer cells, and the underlying molecular mechanism.

Methods

GBM8401 human glioma cells and HeLa cervical carcinoma cells were treated with various concentrations of crude aqueous extracts of P. indica leaf and root and cancer cell proliferation and viability were measured by cell growth curves, trypan blue exclusions, and the tetrazolium reduction assay. Effects of the crude aqueous extracts on focus formation, migration, and apoptosis of cancer cells were studied as well. The molecular mechanism that contributed to the anti-cancer activities of crude aqueous extracts of P. indica root was also examined using Western blotting analysis.

Results

Crude aqueous extracts of P. indica leaf and root suppressed proliferation, viability, and migration of GBM8401 and HeLa cells. Treatment with crude aqueous extracts of P. indica leaf and root for 48 hours resulted in a significant 75% and 70% inhibition on proliferation and viability of GBM8401 and HeLa cancer cells, respectively. Crude aqueous extracts of P. indica root inhibited focus formation and promoted apoptosis of HeLa cells. It was found that phosphorylated-p53 and p21 were induced in GBM8401 and HeLa cells treated with crude aqueous extracts of P. indica root. Expression of phosphorylated-AKT was decreased in HeLa cells treated with crude aqueous extracts of P. indica root.

Conclusion

The in vitro anti-cancer effects of crude aqueous extracts of P. indica leaf and root indicate that it has sufficient potential to warrant further examination and development as a new anti-cancer agent.
Appendix
Available only for authorised users
Literature
1.
go back to reference Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003, 348 (6): 518-527. 10.1056/NEJMoa021641.CrossRefPubMed Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003, 348 (6): 518-527. 10.1056/NEJMoa021641.CrossRefPubMed
2.
go back to reference Wrensch M, Minn Y, Chew T, Bondy M, Berger MS: Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol. 2002, 4 (4): 278-299.PubMedPubMedCentral Wrensch M, Minn Y, Chew T, Bondy M, Berger MS: Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol. 2002, 4 (4): 278-299.PubMedPubMedCentral
3.
go back to reference Smith RR, Malmgren RA: Cancer-cell wound seeding in surgery: a review. CA Cancer J Clin. 1964, 14: 90-103. 10.3322/canjclin.14.3.90. PASSIMCrossRefPubMed Smith RR, Malmgren RA: Cancer-cell wound seeding in surgery: a review. CA Cancer J Clin. 1964, 14: 90-103. 10.3322/canjclin.14.3.90. PASSIMCrossRefPubMed
4.
go back to reference Timmerman RD, Bizekis CS, Pass HI, Fong Y, Dupuy DE, Dawson LA, Lu D: Local surgical, ablative, and radiation treatment of metastases. CA Cancer J Clin. 2009, 59 (3): 145-170. 10.3322/caac.20013.CrossRefPubMed Timmerman RD, Bizekis CS, Pass HI, Fong Y, Dupuy DE, Dawson LA, Lu D: Local surgical, ablative, and radiation treatment of metastases. CA Cancer J Clin. 2009, 59 (3): 145-170. 10.3322/caac.20013.CrossRefPubMed
5.
go back to reference Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY, Olson JJ: Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin. 2010, 60 (3): 166-193. 10.3322/caac.20069.CrossRefPubMedPubMedCentral Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY, Olson JJ: Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin. 2010, 60 (3): 166-193. 10.3322/caac.20069.CrossRefPubMedPubMedCentral
6.
go back to reference Cassileth BR: Evaluating complementary and alternative therapies for cancer patients. CA Cancer J Clin. 1999, 49 (6): 362-375. 10.3322/canjclin.49.6.362.CrossRefPubMed Cassileth BR: Evaluating complementary and alternative therapies for cancer patients. CA Cancer J Clin. 1999, 49 (6): 362-375. 10.3322/canjclin.49.6.362.CrossRefPubMed
7.
go back to reference Sparreboom A, Cox MC, Acharya MR, Figg WD: Herbal remedies in the united states: potential adverse interactions with anticancer agents. J Clin Oncol. 2004, 22 (12): 2489-2503. 10.1200/JCO.2004.08.182.CrossRefPubMed Sparreboom A, Cox MC, Acharya MR, Figg WD: Herbal remedies in the united states: potential adverse interactions with anticancer agents. J Clin Oncol. 2004, 22 (12): 2489-2503. 10.1200/JCO.2004.08.182.CrossRefPubMed
8.
go back to reference Bardia A, Barton DL, Prokop LJ, Bauer BA, Moynihan TJ: Efficacy of complementary and alternative medicine therapies in relieving cancer pain: a systematic review. J Clin Oncol. 2006, 24 (34): 5457-5464. 10.1200/JCO.2006.08.3725.CrossRefPubMed Bardia A, Barton DL, Prokop LJ, Bauer BA, Moynihan TJ: Efficacy of complementary and alternative medicine therapies in relieving cancer pain: a systematic review. J Clin Oncol. 2006, 24 (34): 5457-5464. 10.1200/JCO.2006.08.3725.CrossRefPubMed
9.
go back to reference Boon H, Stewart M, Kennard MA, Gray R, Sawka C, Brown JB, McWilliam C, Gavin A, Baron RA, Aaron D: Use of complementary/alternative medicine by breast cancer survivors in ontario: prevalence and perceptions. J Clin Oncol. 2000, 18 (13): 2515-2521.PubMed Boon H, Stewart M, Kennard MA, Gray R, Sawka C, Brown JB, McWilliam C, Gavin A, Baron RA, Aaron D: Use of complementary/alternative medicine by breast cancer survivors in ontario: prevalence and perceptions. J Clin Oncol. 2000, 18 (13): 2515-2521.PubMed
10.
go back to reference McCulloch M, See C, Shu XJ, Broffman M, Kramer A, Fan WY, Gao J, Lieb W, Shieh K, Colford JM: Astragalus-based chinese herbs and platinum-based chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trials. J Clin Oncol. 2006, 24 (3): 419-430. 10.1200/JCO.2005.03.6392.CrossRefPubMed McCulloch M, See C, Shu XJ, Broffman M, Kramer A, Fan WY, Gao J, Lieb W, Shieh K, Colford JM: Astragalus-based chinese herbs and platinum-based chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trials. J Clin Oncol. 2006, 24 (3): 419-430. 10.1200/JCO.2005.03.6392.CrossRefPubMed
11.
go back to reference Sen T, Dhara AK, Bhattacharjee S, Pal S, Nag chaudhuri AK: Antioxidant activity of the methanol fraction of pluchea indica root extract. Phytother Res. 2002, 16 (4): 331-335. 10.1002/ptr.892.CrossRefPubMed Sen T, Dhara AK, Bhattacharjee S, Pal S, Nag chaudhuri AK: Antioxidant activity of the methanol fraction of pluchea indica root extract. Phytother Res. 2002, 16 (4): 331-335. 10.1002/ptr.892.CrossRefPubMed
12.
go back to reference Sen T, Nag chaudhuri AK: Antiinflammatory evaluation of a pluchea indica root extract. J Ethnopharmacol. 1991, 33 (1–2): 135-141.CrossRefPubMed Sen T, Nag chaudhuri AK: Antiinflammatory evaluation of a pluchea indica root extract. J Ethnopharmacol. 1991, 33 (1–2): 135-141.CrossRefPubMed
13.
go back to reference Gomes A, Saha A, Chatterjee I, Chakravarty AK: Viper and cobra venom neutralization by beta-sitosterol and stigmasterol isolated from the root extract of pluchea indica less. (Asteraceae). Phytomedicine. 2007, 14 (9): 637-643. 10.1016/j.phymed.2006.12.020.CrossRefPubMed Gomes A, Saha A, Chatterjee I, Chakravarty AK: Viper and cobra venom neutralization by beta-sitosterol and stigmasterol isolated from the root extract of pluchea indica less. (Asteraceae). Phytomedicine. 2007, 14 (9): 637-643. 10.1016/j.phymed.2006.12.020.CrossRefPubMed
14.
go back to reference Sen T, Ghosh TK, Chaudhuri AK: Studies on the mechanism of anti-inflammatory and anti-ulcer activity of pluchea indica–probable involvement of 5-lipooxygenase pathway. Life Sci. 1993, 52 (8): 737-743. 10.1016/0024-3205(93)90236-V.CrossRefPubMed Sen T, Ghosh TK, Chaudhuri AK: Studies on the mechanism of anti-inflammatory and anti-ulcer activity of pluchea indica–probable involvement of 5-lipooxygenase pathway. Life Sci. 1993, 52 (8): 737-743. 10.1016/0024-3205(93)90236-V.CrossRefPubMed
15.
go back to reference Mohamad S, Zin NM, Wahab HA, Ibrahim P, Sulaiman SF, Zahariluddin AS, Noor SS: Antituberculosis potential of some ethnobotanically selected malaysian plants. J Ethnopharmacol. 2011, 133 (3): 1021-1026. 10.1016/j.jep.2010.11.037.CrossRefPubMed Mohamad S, Zin NM, Wahab HA, Ibrahim P, Sulaiman SF, Zahariluddin AS, Noor SS: Antituberculosis potential of some ethnobotanically selected malaysian plants. J Ethnopharmacol. 2011, 133 (3): 1021-1026. 10.1016/j.jep.2010.11.037.CrossRefPubMed
16.
go back to reference Li XK, Motwani M, Tong W, Bornmann W, Schwartz GK: Huanglian, a chinese herbal extract, inhibits cell growth by suppressing the expression of cyclin B1 and inhibiting CDC2 kinase activity in human cancer cells. Mol Pharmacol. 2000, 58 (6): 1287-1293.PubMed Li XK, Motwani M, Tong W, Bornmann W, Schwartz GK: Huanglian, a chinese herbal extract, inhibits cell growth by suppressing the expression of cyclin B1 and inhibiting CDC2 kinase activity in human cancer cells. Mol Pharmacol. 2000, 58 (6): 1287-1293.PubMed
17.
go back to reference Harborne JB: Phytochemical methods: a guide to modern techniques of plant analysis. 1998, London, New York: Chapman and Hall, 3 Harborne JB: Phytochemical methods: a guide to modern techniques of plant analysis. 1998, London, New York: Chapman and Hall, 3
18.
go back to reference Butler LG, Price ML, Brotherton JE: Vanillin assay for proanthocyanidins (condensed tannins): modification of the solvent for estimation of the degree of polymerization. J Agric Food Chem. 1982, 49 (3): 1169-1174. Butler LG, Price ML, Brotherton JE: Vanillin assay for proanthocyanidins (condensed tannins): modification of the solvent for estimation of the degree of polymerization. J Agric Food Chem. 1982, 49 (3): 1169-1174.
19.
go back to reference Janero DR: Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med. 1990, 9 (6): 515-540. 10.1016/0891-5849(90)90131-2.CrossRefPubMed Janero DR: Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med. 1990, 9 (6): 515-540. 10.1016/0891-5849(90)90131-2.CrossRefPubMed
20.
go back to reference West KA, Zhang H, Brown MC, Nikolopoulos SN, Riedy MC, Horwitz AF, Turner CE: The LD4 motif of paxillin regulates cell spreading and motility through an interaction with paxillin kinase linker (PKL). J Cell Biol. 2001, 154 (1): 161-176. 10.1083/jcb.200101039.CrossRefPubMedPubMedCentral West KA, Zhang H, Brown MC, Nikolopoulos SN, Riedy MC, Horwitz AF, Turner CE: The LD4 motif of paxillin regulates cell spreading and motility through an interaction with paxillin kinase linker (PKL). J Cell Biol. 2001, 154 (1): 161-176. 10.1083/jcb.200101039.CrossRefPubMedPubMedCentral
21.
go back to reference Wink M, Ashour ML, El-Readi MZ: Secondary metabolites from plants inhibiting ABC transporters and reversing resistance of cancer cells and microbes to cytotoxic and antimicrobial agents. Front Microbiol. 2012, 3: 130-CrossRefPubMedPubMedCentral Wink M, Ashour ML, El-Readi MZ: Secondary metabolites from plants inhibiting ABC transporters and reversing resistance of cancer cells and microbes to cytotoxic and antimicrobial agents. Front Microbiol. 2012, 3: 130-CrossRefPubMedPubMedCentral
22.
go back to reference Zamora-Ros R, Agudo A, Lujan-Barroso L, Romieu I, Ferrari P, Knaze V, Bueno-de-Mesquita HB, Leenders M, Travis RC, Navarro C: Dietary flavonoid and lignan intake and gastric adenocarcinoma risk in the european prospective investigation into cancer and nutrition (EPIC) study. Am J Clin Nutr. 2012, 96 (6): 1398-1408. 10.3945/ajcn.112.037358.CrossRefPubMed Zamora-Ros R, Agudo A, Lujan-Barroso L, Romieu I, Ferrari P, Knaze V, Bueno-de-Mesquita HB, Leenders M, Travis RC, Navarro C: Dietary flavonoid and lignan intake and gastric adenocarcinoma risk in the european prospective investigation into cancer and nutrition (EPIC) study. Am J Clin Nutr. 2012, 96 (6): 1398-1408. 10.3945/ajcn.112.037358.CrossRefPubMed
23.
go back to reference Law PC, Auyeung KK, Chan LY, Ko JK: Astragalus saponins downregulate vascular endothelial growth factor under cobalt chloride-stimulated hypoxia in colon cancer cells. BMC Complement Altern Med. 2012, 12: 160-10.1186/1472-6882-12-160.CrossRefPubMedPubMedCentral Law PC, Auyeung KK, Chan LY, Ko JK: Astragalus saponins downregulate vascular endothelial growth factor under cobalt chloride-stimulated hypoxia in colon cancer cells. BMC Complement Altern Med. 2012, 12: 160-10.1186/1472-6882-12-160.CrossRefPubMedPubMedCentral
24.
go back to reference Prasad R, Vaid M, Katiyar SK: Grape proanthocyanidin inhibit pancreatic cancer cell growth in vitro and in vivo through induction of apoptosis and by targeting the PI3K/Akt pathway. PLoS One. 2012, 7 (8): e43064-10.1371/journal.pone.0043064.CrossRefPubMedPubMedCentral Prasad R, Vaid M, Katiyar SK: Grape proanthocyanidin inhibit pancreatic cancer cell growth in vitro and in vivo through induction of apoptosis and by targeting the PI3K/Akt pathway. PLoS One. 2012, 7 (8): e43064-10.1371/journal.pone.0043064.CrossRefPubMedPubMedCentral
25.
go back to reference Ghavami G, Sardari S, Ali Shokrgozar M: Cheminformatics-based selection and synergism of herbal extracts with anticancer agents on drug resistance tumor cells-ACHN and A2780/CP cell lines. Comput Biol Med. 2011, 41 (8): 665-674. 10.1016/j.compbiomed.2011.06.002.CrossRefPubMed Ghavami G, Sardari S, Ali Shokrgozar M: Cheminformatics-based selection and synergism of herbal extracts with anticancer agents on drug resistance tumor cells-ACHN and A2780/CP cell lines. Comput Biol Med. 2011, 41 (8): 665-674. 10.1016/j.compbiomed.2011.06.002.CrossRefPubMed
26.
go back to reference Tsai NM, Chen YL, Lee CC, Lin PC, Cheng YL, Chang WL, Lin SZ, Harn HJ: The natural compound n-butylidenephthalide derived from angelica sinensis inhibits malignant brain tumor growth in vitro and in vivo. J Neurochem. 2006, 99 (4): 1251-1262. 10.1111/j.1471-4159.2006.04151.x.CrossRefPubMedPubMedCentral Tsai NM, Chen YL, Lee CC, Lin PC, Cheng YL, Chang WL, Lin SZ, Harn HJ: The natural compound n-butylidenephthalide derived from angelica sinensis inhibits malignant brain tumor growth in vitro and in vivo. J Neurochem. 2006, 99 (4): 1251-1262. 10.1111/j.1471-4159.2006.04151.x.CrossRefPubMedPubMedCentral
27.
go back to reference Kumar AP, Bhaskaran S, Ganapathy M, Crosby K, Davis MD, Kochunov P, Schoolfield J, Yeh IT, Troyer DA, Ghosh R: Akt/cAMP-responsive element binding protein/cyclin D1 network: a novel target for prostate cancer inhibition in transgenic adenocarcinoma of mouse prostate model mediated by nexrutine, a phellodendron amurense bark extract. Clin Cancer Res. 2007, 13 (9): 2784-2794. 10.1158/1078-0432.CCR-06-2974.CrossRefPubMedPubMedCentral Kumar AP, Bhaskaran S, Ganapathy M, Crosby K, Davis MD, Kochunov P, Schoolfield J, Yeh IT, Troyer DA, Ghosh R: Akt/cAMP-responsive element binding protein/cyclin D1 network: a novel target for prostate cancer inhibition in transgenic adenocarcinoma of mouse prostate model mediated by nexrutine, a phellodendron amurense bark extract. Clin Cancer Res. 2007, 13 (9): 2784-2794. 10.1158/1078-0432.CCR-06-2974.CrossRefPubMedPubMedCentral
28.
go back to reference Vousden KH, Prives C: Blinded by the light: the growing complexity of p53. Cell. 2009, 137 (3): 413-431. 10.1016/j.cell.2009.04.037.CrossRefPubMed Vousden KH, Prives C: Blinded by the light: the growing complexity of p53. Cell. 2009, 137 (3): 413-431. 10.1016/j.cell.2009.04.037.CrossRefPubMed
29.
go back to reference Vogelstein B, Lane D, Levine AJ: Surfing the p53 network. Nature. 2000, 408 (6810): 307-310. 10.1038/35042675.CrossRefPubMed Vogelstein B, Lane D, Levine AJ: Surfing the p53 network. Nature. 2000, 408 (6810): 307-310. 10.1038/35042675.CrossRefPubMed
30.
go back to reference Chen TP, Chen CM, Chang HW, Wang JS, Chang WC, Hsu SI, Cho CL: Increased expression of SKP2 and phospho-MAPK/ERK1/2 and decreased expression of p27 during tumor progression of cervical neoplasms. Gynecol Oncol. 2007, 104 (3): 516-523. 10.1016/j.ygyno.2006.09.015.CrossRefPubMed Chen TP, Chen CM, Chang HW, Wang JS, Chang WC, Hsu SI, Cho CL: Increased expression of SKP2 and phospho-MAPK/ERK1/2 and decreased expression of p27 during tumor progression of cervical neoplasms. Gynecol Oncol. 2007, 104 (3): 516-523. 10.1016/j.ygyno.2006.09.015.CrossRefPubMed
31.
go back to reference Brady CA, Jiang D, Mello SS, Johnson TM, Jarvis LA, Kozak MM, Kenzelmann Broz D, Basak S, Park EJ, McLaughlin ME: Distinct p53 transcriptional programs dictate acute DNA-damage responses and tumor suppression. Cell. 2011, 145 (4): 571-583. 10.1016/j.cell.2011.03.035.CrossRefPubMedPubMedCentral Brady CA, Jiang D, Mello SS, Johnson TM, Jarvis LA, Kozak MM, Kenzelmann Broz D, Basak S, Park EJ, McLaughlin ME: Distinct p53 transcriptional programs dictate acute DNA-damage responses and tumor suppression. Cell. 2011, 145 (4): 571-583. 10.1016/j.cell.2011.03.035.CrossRefPubMedPubMedCentral
32.
go back to reference Chen K, Albano A, Ho A, Keaney JF: Activation of p53 by oxidative stress involves platelet-derived growth factor-beta receptor-mediated ataxia telangiectasia mutated (ATM) kinase activation. J Biol Chem. 2003, 278 (41): 39527-39533. 10.1074/jbc.M304423200.CrossRefPubMed Chen K, Albano A, Ho A, Keaney JF: Activation of p53 by oxidative stress involves platelet-derived growth factor-beta receptor-mediated ataxia telangiectasia mutated (ATM) kinase activation. J Biol Chem. 2003, 278 (41): 39527-39533. 10.1074/jbc.M304423200.CrossRefPubMed
33.
go back to reference Guo Z, Kozlov S, Lavin MF, Person MD, Paull TT: ATM activation by oxidative stress. Science. 2010, 330 (6003): 517-521. 10.1126/science.1192912.CrossRefPubMed Guo Z, Kozlov S, Lavin MF, Person MD, Paull TT: ATM activation by oxidative stress. Science. 2010, 330 (6003): 517-521. 10.1126/science.1192912.CrossRefPubMed
34.
go back to reference Seoane J, Le HV, Massague J: Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature. 2002, 419 (6908): 729-734. 10.1038/nature01119.CrossRefPubMed Seoane J, Le HV, Massague J: Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature. 2002, 419 (6908): 729-734. 10.1038/nature01119.CrossRefPubMed
35.
go back to reference Koz ST, Etem EO, Baydas G, Yuce H, Ozercan HI, Kuloglu T, Koz S, Etem A, Demir N: Effects of resveratrol on blood homocysteine level, on homocysteine induced oxidative stress, apoptosis and cognitive dysfunctions in rats. Brain Res. 2012, 1484: 29-38.CrossRefPubMed Koz ST, Etem EO, Baydas G, Yuce H, Ozercan HI, Kuloglu T, Koz S, Etem A, Demir N: Effects of resveratrol on blood homocysteine level, on homocysteine induced oxidative stress, apoptosis and cognitive dysfunctions in rats. Brain Res. 2012, 1484: 29-38.CrossRefPubMed
36.
go back to reference Bresgen N, Jaksch H, Lacher H, Ohlenschlager I, Uchida K, Eckl PM: Iron-mediated oxidative stress plays an essential role in ferritin-induced cell death. Free Radic Biol Med. 2010, 48 (10): 1347-1357. 10.1016/j.freeradbiomed.2010.02.019.CrossRefPubMed Bresgen N, Jaksch H, Lacher H, Ohlenschlager I, Uchida K, Eckl PM: Iron-mediated oxidative stress plays an essential role in ferritin-induced cell death. Free Radic Biol Med. 2010, 48 (10): 1347-1357. 10.1016/j.freeradbiomed.2010.02.019.CrossRefPubMed
37.
go back to reference Feng Z, Hu W, Tang MS: Trans-4-hydroxy-2-nonenal inhibits nucleotide excision repair in human cells: a possible mechanism for lipid peroxidation-induced carcinogenesis. Proc Natl Acad Sci USA. 2004, 101 (23): 8598-8602. 10.1073/pnas.0402794101.CrossRefPubMedPubMedCentral Feng Z, Hu W, Tang MS: Trans-4-hydroxy-2-nonenal inhibits nucleotide excision repair in human cells: a possible mechanism for lipid peroxidation-induced carcinogenesis. Proc Natl Acad Sci USA. 2004, 101 (23): 8598-8602. 10.1073/pnas.0402794101.CrossRefPubMedPubMedCentral
38.
go back to reference Lee YJ, Lee JH, Han HJ: Extracellular adenosine triphosphate protects oxidative stress-induced increase of p21(WAF1/Cip1) and p27(Kip1) expression in primary cultured renal proximal tubule cells: role of PI3K and Akt signaling. J Cell Physiol. 2006, 209 (3): 802-810. 10.1002/jcp.20763.CrossRefPubMed Lee YJ, Lee JH, Han HJ: Extracellular adenosine triphosphate protects oxidative stress-induced increase of p21(WAF1/Cip1) and p27(Kip1) expression in primary cultured renal proximal tubule cells: role of PI3K and Akt signaling. J Cell Physiol. 2006, 209 (3): 802-810. 10.1002/jcp.20763.CrossRefPubMed
39.
go back to reference Bellacosa A, Kumar CC, Di Cristofano A, Testa JR: Activation of AKT kinases in cancer: implications for therapeutic targeting. Adv Cancer Res. 2005, 94: 29-86.CrossRefPubMed Bellacosa A, Kumar CC, Di Cristofano A, Testa JR: Activation of AKT kinases in cancer: implications for therapeutic targeting. Adv Cancer Res. 2005, 94: 29-86.CrossRefPubMed
40.
go back to reference Zhou BP, Hung MC: Novel targets of Akt, p21(cipl/WAF1), and MDM2. Semin Oncol. 2002, 29 (3 Suppl 11): 62-70. 10.1053/sonc.2002.34057.CrossRefPubMed Zhou BP, Hung MC: Novel targets of Akt, p21(cipl/WAF1), and MDM2. Semin Oncol. 2002, 29 (3 Suppl 11): 62-70. 10.1053/sonc.2002.34057.CrossRefPubMed
41.
42.
go back to reference Tsao AS, McDonnell T, Lam S, Putnam JB, Bekele N, Hong WK, Kurie JM: Increased phospho-AKT (Ser(473)) expression in bronchial dysplasia: implications for lung cancer prevention studies. Cancer Epidemiol Biomarkers Prev. 2003, 12 (7): 660-664.PubMed Tsao AS, McDonnell T, Lam S, Putnam JB, Bekele N, Hong WK, Kurie JM: Increased phospho-AKT (Ser(473)) expression in bronchial dysplasia: implications for lung cancer prevention studies. Cancer Epidemiol Biomarkers Prev. 2003, 12 (7): 660-664.PubMed
43.
go back to reference Balsara BR, Pei J, Mitsuuchi Y, Page R, Klein-Szanto A, Wang H, Unger M, Testa JR: Frequent activation of AKT in non-small cell lung carcinomas and preneoplastic bronchial lesions. Carcinogenesis. 2004, 25 (11): 2053-2059. 10.1093/carcin/bgh226.CrossRefPubMed Balsara BR, Pei J, Mitsuuchi Y, Page R, Klein-Szanto A, Wang H, Unger M, Testa JR: Frequent activation of AKT in non-small cell lung carcinomas and preneoplastic bronchial lesions. Carcinogenesis. 2004, 25 (11): 2053-2059. 10.1093/carcin/bgh226.CrossRefPubMed
44.
go back to reference Frida L, Rakotonirina S, Rakotonirina A, Savineau JP: In vivo and in vitro effects of bidens pilosa L. (Asteraceae) leaf aqueous and ethanol extracts on primed-oestrogenized rat uterine muscle. Afr J Tradit Complement Altern Med. 2007, 5 (1): 79-91.PubMedPubMedCentral Frida L, Rakotonirina S, Rakotonirina A, Savineau JP: In vivo and in vitro effects of bidens pilosa L. (Asteraceae) leaf aqueous and ethanol extracts on primed-oestrogenized rat uterine muscle. Afr J Tradit Complement Altern Med. 2007, 5 (1): 79-91.PubMedPubMedCentral
Metadata
Title
Crude aqueous extracts of Pluchea indica (L.) Less. inhibit proliferation and migration of cancer cells through induction of p53-dependent cell death
Authors
Jonathan J Cho
Chung-Lung Cho
Chiu-Li Kao
Chien-Ming Chen
Chao-Neng Tseng
Ya-Zhe Lee
Li-Jen Liao
Yi-Ren Hong
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2012
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/1472-6882-12-265

Other articles of this Issue 1/2012

BMC Complementary Medicine and Therapies 1/2012 Go to the issue